Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis.
Respir Med. 1995 Aug;89(7):499-502. doi: 10.1016/0954-6111(95)90126-4.
Respir Med. 1995.
PMID: 7480980
Clinical Trial.